They found that the imatinib response in GIST patients is maintained through autophagy, rather than apoptosis, based on the expression of autophagy‐related proteins such as beclin1, PI3KI, and PI3KIII in the surgical samples [132]. The gene discussed is BECN1; the disease is gastrointestinal stromal tumor.